Healthcare / Cell Therapy Market - Global Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Players: Gilead Sciences, Novartis, Vcanbio, Fujifilm Cellular Dynamics
Cell Therapy Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Gilead Sciences, Novartis, Vcanbio, Fujifilm Cellular Dynamics
The Cell Therapy market is estimated to grow at a CAGR of 14.8% over the forecast period, from USD 8.2 billion in 2021 to USD 13.1 billion by 2027.
Cell Therapy Market Overview
Cell therapy is a method of treating damaged or defective cells by replacing them with healthy, functional cells. Because of their potential to develop into specific cells required for healing damaged or malfunctioning tissues or cells, stem cells are commonly used in such sophisticated therapies. The growing number of clinical trials for cell-based therapeutics is driving the industry. As a result, there has been a significant increase in global investment in research and clinical translation. The presence of government and commercial funding agencies that are continually issuing grants to support projects at various phases of clinical trials can be ascribed to the growing number of ongoing clinical studies.
The acceptance of human cells for cell therapies research, technological improvements in the field of cell treatment, and an increase in the occurrences of diseases such as cancer and cardiac abnormalities are the key drivers driving market growth. Furthermore, the cell treatment market is expected to be constrained by the installation of strong government rules governing the use of cell therapy. On the contrary, a rise in the number of rules promoting stem cell therapy and an increase in research funding in emerging nations are projected to provide profitable prospects for the market in the future.
Industry News and Updates
May 28, 2022:FDA approves Novartis Kymriah CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma --
Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah (tisagenlecleucel) for the treatment of adult patients with relapsed or refractory (r/r) follicular lymphoma (FL) after two or more lines of systemic therapy. In accordance with the Accelerated Approval Program, continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s). Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings1.
What are the major Applications, Types and Regions for Cell Therapy Market?
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
Stem Cell
Non-Stem Cell
By Application, it is segmented into
Hospital
Clinic
Cell Therapy Market Regional Analysis
North America is expected to have the greatest market share of 52.7% in 2020. The existence of a high number of centres and institutes working in stem cell treatment research and development accounts for the region's large share. Five of the eight top colleges in the world are headquartered in the United States, including Stanford University's Institute for Stem Cell Biology and Regenerative Medicine, Harvard University's Harvard Stem Cell Institute, and Yale University's Yale Stem Cell Center. Cell therapy is expected to increase at a lucrative rate of 15.52% in Asia Pacific over the forecast period. The growing investment by developers and customers in self-education for advanced medicinal therapies is expected to improve revenue generated by the region's emerging economies. In Asian countries, there are a number of stem cell consortiums whose goal is to ensure that R&D projects are well-coordinated and targeted. Furthermore, because of the legal framework's flexibility, patients from Western countries have been spotted migrating to Asian countries for treatment.
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Cell Therapy Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Cell Therapy Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Cell Therapy Market report scope?
Report Attributes
Report Details
Forecast Period 2022 to 2027 CAGR
CAGR of 14.8% over the forecast period (2022-2027)
What are the significant types of Cell Therapy Market?
Stem Cell, Non-Stem Cell
What are the major end-use applications of Cell Therapy Market?
Hospital, Clinic
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
